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Summary 
The cap3B gene, which is involved in the formation of the capsule of Streptococcus pneumoniae 
type 3, encodes a 49-kD protein that has been identified as a polysaccharide synthase. Escheri- 
chia coli cells harboring the recombinant plasmid pTBP3 (cap3B) produced pneumococcal type 
3 polysaccharide, as demonstrated by immunological tests. Biochemical and cell fractionation 
analyses revealed that this polysaccharide had a high molecular mass and was localized in sub- 
stantial amounts in the periplasmic space orE. coli. Unencapsulated ($2-), laboratory pneumo- 
coccal strains synthesized type 3 polysaccharide by transformation with plasmid pLSE3B har- 
boring cap3B. In addition, encapsulated pneumococci of types 1, 2, 5, or 8 transformed with 
pLSE3B can direct the synthesis ofpneumococcal type 3 polysaccharide, l ading to the forma- 
tion of strains that display binary type of capsule. 
C apsular polysaccharide protects bacteria from phago- cytosis by polymorphonuclear leukocytes, and the vir- 
ulence of Streptococcus pneumoniae is determined by the size 
and the chemical composition of the capsule (1). 90 differ- 
ent capsular types of S. pneumoniae have been described (2) 
and variations in capsular serotype by in vivo and in vitro 
experiments led to the identification f DNA as the "tram- 
forming principle" (3, 4). The importance of these types of
genetic exchanges in nature has recently been suggested as 
a source of variation of the different pneumococcal strains 
to expand their capacity of colonizing the host organism (5). 
Type 3 pneumococci produce a capsule composed of 
cellobiuronic acid units connected in a [3(1-+3) linkage (6). 
Cellobiuronic acid is a disaccharide consisting of D-glucu- 
ronic acid (GlcA) 1 [3(1-+4) linked to D-glucose (Glc). Re- 
cently, the genes implicated in the biosynthesis of type 3 
capsular polysaccharide have been cloned and some of them 
have been partially characterized (7-12). At least three type 
3-specific genes have been found, namely, cap3A, B, and C 
(also designated as cps3D, S and U, respectively). Genetic 
and biochemical nalyses howed that Cap3A is a UDP-Glc 
dehydrogenase that converts UDP-Glc into UDP-GlcA (8, 
12), whereas cap3 C complements the galU defect of Escherichia 
coli and, therefore, codes for a UDP-Glc pyrophosphorylase 
(11). On the other hand, sequence comparison uggested 
that cap3B might code for the type-specific polysaccharide 
synthase, although a precise settlement could not be reached 
~Abbreviations used in this paper: Glc, glucose; GlcA, glucuronic acid; 
IPTG, isopropyl-[3-D-thiogalactopyranoside. 
at that moment. The genes cap3A, B, and C are transcribed 
together, and insertion-duplication mutagenesis revealed 
that cap3C is not essential for capsule formation (11). Clas- 
sical genetic studies ofpneumococcal capsular type 3 strains 
suggested that all but one of the spontaneous mutations that 
alter the formation of type 3 polysaccharide were located in 
cap3A (13). Several cap3A point mutations have now been 
characterized, and some of them completely blocked the 
synthesis of type 3 polysaccharide (8, 10), whereas only a 
deletion affecting simultaneously cap3A and cap3B (13) or 
insertion mutations (10) affecting cap3B have been reported 
so far. Since polar effects are likely to occur as a conse- 
quence of plasrnid or transposon insertion, a definite con- 
clusion on the role of Cap3B on capsular biosynthesis still 
awaited the isolation and characterization of cap3B point 
mutants. 
In this communication, we report he isolation and char- 
acterization ofa cap3B mutant. We also show that Cap3B is 
a synthase that led to the synthesis of type 3 pneumococcal 
polysaccharide of high molecular mass in E. roll, and that 
was sufficient o produce binary capsulated strains when 
cloned into several S. pneumoniae ncapsulated strains be- 
longing to several serotypes. 
Materials and Methods 
Bacterial Strains, Plasmids and Growth Conditions. The type 3 S. 
pneumoniae strain 406 has been described elsewhere (7). The 
pneumococcal strain M25, a type 1 encapsulated derivative of the 
laboratory strain M24 (7), was constructed by M. Mollerach in 
our laboratory by transformation with DNA from a type 1 clini- 
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cal isolate of S. pneumoniae. Other pneumococcal strains were 
clinical isolates belonging to serotypes 2 (15783/94), 5 (8595/95), 
and 8 (6028), and were provided by A. Fenoll from the Spanish 
Reference Laboratory for Pneumococci (Instituto de Salud Car- 
los III, Majadahonda, Madrid). The unencapsulated $3- strain 
NP,.3-10 is a spontaneous nmtant of the pneumococcal strain 
NS3-1 (8), isolated as described elsewhere in detail (7). Two non- 
encapsulated ($2-) mutants used in some experiments were the 
laboratory strains Ml l  and M31 (14). These strains were late de- 
scendants of the strain R36A (4). S. pneumoniae strains were 
grown in liquid C+Y medium (7) or on reconstituted tryptose 
blood agar base plates (Difco Laboratories, Detroit, MI) supple- 
mented with 5% (vol/vol) defibrinated sheep blood. Serotyping 
was carried out by the "Quellung" reaction with type-specific anti- 
sera purchased from the Staten Seruminstitut (Copenhagen, Den- 
mark) (15). The same antisera were used for other immunological 
techniques ( ee below). E. coli strains BL21(DE3) (16), C600 (17), 
and DH10B (F' mcrA A(mrr hsdRMS-mcrBC) ~80dlacZA M15 
AlacX74 deoR recAl araD139 A(ara-leu)7697 galU galK X- rpsL 
endA I nupG) (Life Technologies) were used as hosts for recombi- 
nant plasmids and grown in LB medimn (17). Plasmids pLysS (16), 
pT7-7 (18), pLSE1 (19), and pKEP,2, pKER22, and pKEP,23 (8) 
have been already described. 
DNA Manipulation, Plasmid Construction, and Genetic Transfor- 
mation. Preparation of plasmid DNA, digestion with restriction 
endonucleases, ligation reactions, and agarose gel electrophoresis 
followed standard procedures (17). PCR amplification of cap3B 
was performed by using 2 U of Taq polymerase (Perkin-Elmer 
Cetus Corp., Norwalk, CT), 10 ng ofplasmid pKER2, 1 I~M of 
each synthetic oligonucleotide primer, 250 bLM of each dNTP, 
and 5 mM MgC12 in the buffer recommended by the manu- 
facturers. Amplification was achieved with a cycle of 3 rain dena- 
turation at 95~ 2 min annealing at 69~ and 5 rain polymerase 
extension at 72~ repeated 40 times wi h a final 6-rain extension 
at 72~ and slow cooling to 4~ with a Gene ATAQ controller 
(Pharmacia LKI~, Piscataway, NJ). The following synthetic oligo- 
nucleotides were used: PCAP3B (5'-CTATACACGCGATT- 
CATATGGCAGAG-3') and PCAP21 (5'-GTGTGCCCAGCC- 
CTGCAGC-3'); the underlined sequence indicates restriction 
site for NdeI. Transformation f competent cells of S. pneumoniae 
(19) and E. coli (17) have been described. Before addition of 
transforming DNA, clinical isolates of S. pneumoniae were incu- 
bated with a crude preparation of competence factor, as previ- 
ously reported (20). Transformants of S. pneumoniae and E. coil 
obtained with plasnfids derived from pLSE1 were selected by 
plating with lincomycin (1 txg/ml), or erythromycin (500 I~g/ 
ml), respectively. When pT7-7 or its derivative pTBP3 (see be- 
low) were used as donor DNAs, E. coli BL21(DE3)pLysS trans- 
formants were scored on LB agar plates containing chlorampheni- 
col (20 ~g/ml) and ampicillin (75 btg/ml). DNA sequencing was 
carried out with appropriate oligonucleotides with an Abi Prism 
377 DNA Sequencer (Perkin-Elmer Cetus). 
Characterization f Capsular Polysaccharide. Highly purified pneu- 
mococcal polysaccharides were prepared essentially as described else- 
where (15). Briefly, exponentially growing cultures of S. pneu- 
moniae in C+Y n~edium were lysed by the addition of 1% sodium 
deoxycholate (final concentration) and incubation at 37~ for 30 
rain. When lytA mutants were used, cells were incubated with 5 
p~g/ml of LytA pneumococcal autolysin (6 • 1() ~ U/mg) for 30 
miu at 37~ before the addition of sodium deoxycholate. The ly- 
sate was acidified with acetic acid (0.5% final concentration) and 
heated to boiling point. After cooling, the mixture was neutral- 
ized with NaOH and deproteinized with chloroform/isoamyl al- 
cohol (24:1). The polysaccharide was precipitated by adding 2 vol 
of cold absolute thanol. After standing overnight at 4~ the pre- 
cipitate was recovered by centrifugation (10,000 g for 30 rain), 
washed once with 96% ethanol, twice with diethyl ether, and 
dried at 65~ The polysaccharide was dissolved in distilled water 
and deproteinized again twice with phenol/chloroform/isoamyl 
alcohol (25:24:1) and once more with chloroform/isoamyl alco- 
hol. Afterwards, the aqueous phase received sodium acetate (final 
concentration = 5%), and the polysaccharide was precipitated 
with half its volume of isopropanol. After standing overnight at 
4~ the polysaccharide was washed as described above, dried, 
and dissolved in distilled water. For rapid, crude preparations of 
pneumococcal polysaccharides, 1.5 ml of late exponentially grow- 
ing cultures of S. p~ieumoniae w re treated as described above, ex- 
cept that the deproteinization step was excluded, and the polysac- 
charide was precipitated only once with absolute ethanol and 
dissolved in 100 I~1 of distilled water. 
The uronic acid content of the purified type 3 polysaccharide 
was measured by the carbazole assay (21) with glucuronic acid as 
the standard. The mass of the polymers was determined by gel fil- 
tration (22) with Sepharose CL-4B (Pharmacia Biotech, Uppsala, 
Sweden). Double-diffusion experiments were performed on 0.7% 
agarose-coated microscope slides as previously described (23). To 
estimate the amount of type 3 polysaccharide pr sent in a sample, 
5 btl of serial dilutions of the extract and known amounts of puri- 
fied polysaccharide w re analyzed by immunodiffusion against 5 btl 
of the same batch of type 3 antiserum. In these experimental con- 
ditions, 0.25 ~g of type 3 polysaccharide is enough to give a tiny 
but still visible precipitation band after overnight incubation. 
Miscellaneous Techniques. SDS-PAGE was carried out as de- 
scribed by Laemmli (24). After SDS-PAGE, proteins were blotted 
onto a polyvinylidene dittuoride membrane (Immobilon-pSQ; Milli- 
pore Corp., Bedford, MA), and stained briefly with amido black 
(Sigma Immunochemicals, St. Louis, MO). Subsequently, the de- 
sired band was cut and the NH2-terminal mino acid sequence 
was detemfined asdescribed elsewhere (25). Preparation ofsphero- 
plasts and fractionation of E. coli cells were carried out as previ- 
ously described (26). 
Results 
cap3B Is hwolved in Capsular Biosynthesis. We reported 
previously the isolation of 12 spontaneous $3- strains that 
were characterized ascap3A nmtants on the basis of trans- 
formation to the smooth phenotype with the wild-type 
cap3A gene (8). In a subsequent round of isolation of rough 
mutants, however, one of them (strain NP,3-10) was not 
transformed to the $3 + phenotype by the cap3A + allele, 
and was studied in detail. When the cap3B gene of the 
wild-type strain 406 was amplified by PCR and used to 
transform competent NR.3-10 cells, fully capsulated trans- 
formants were obtained (Fig. 1). The mutation could be 
mapped more accurately by transformation experiments 
with different restriction fragnnents of cap3B. Sequence anal- 
ysis of the PCR.-amplified cap3B allele of NR3-10 revealed 
the insertion of an additional single base (T) in a preexistent 
run of six T's and close to the 5' end of the wild-type gene, 
causing the appearance of a termination codon (TAA) 
some 50 nucleotides downstream of the insertion. To ex- 
clude the possibility of an artifact introduced uring the 
PCR amplification, several PC1K rounds were carried out, 
450 Type 3 Pneumococcal Polysaccharide Synthase 
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Figure 1. Partial restriction map, genetic organiza- 
tion of the cap3ABC operon, and characterization of 
the NR3-10 cap3B mutant strain. (A) Only those re- 
striction sites that are pertinent to this work are indi- 
cated. A, Accl; H, HindlII; M, Munl; P, Pvull; Ps, 
PstI; S, ScaI. Triangles indicate the location and direc- 
tion of the oligonucleotide primers PCAP3B (1~) and 
PCAP21 (D). (B) Transformation experiments to the 
capsulated $3 + phenotype. Competent cells of the
cap3B mutant (NR3-10) were incubated with DNA 
fragments, either PCR amplified or isolated from an 
agarose gel after digestion with a restriction endonu- 
clease (open bars) or plasmids. Formation (or not) of $3 + 
transfonnants is indicated by + (or-). (C) The nucle- 
otide sequence of the relevant region of the cap3B + al- 
lele (strain 406) and of the mutant NR3-10 are indi- 
cated. Numbers in parenthesis indicate the nudeotide 
position taking as +1 the first nucleotide of the ATG 
start codon of the cap3B gene (11). 
and the corresponding products were sequenced. In addi- 
tion, the sequence previously reported for the wild-type 
gene (11) was fully confirmed by direct sequencing of the 
PCR-amplif ied cap3B gene of the 406 strain. These results 
taken together demonstrated that Cap3B directly partici- 
pates in the synthesis of type 3 pneumococcal polysaccharide. 
The frameshifting that originated in the strain NR3-10 
should cause the synthesis of a truncated, and possibly inac- 
tive, Cap3B protein. Nevertheless, a closer inspection of 
NR3-10 revealed the presence of a small amount of type 3 
capsular polysaccharide (~-,10% of that found in the wild- 
type strain; not shown). This finding might be explained as 
the result of the slippage of one nucleotide during transla- 
tion of the mRNA of the mutant strain, as already de- 
scribed for several genes in other species (27). 
Cloning and Expression of cap3B in E. coli. Several groups 
have experienced severe difficulties in cloning the func- 
tional pneumococcal genes in E. coli. In particular, expres- 
sion of cap3B in E. coli was lethal to the host and, conse- 
quently, characterization of the enzyme could not be 
achieved (10). To overcome this problem, we tried to 
clone cap3B under the control of the T7 promoter as 
shown in Fig. 2. In short, a DNA fragment containing cap3B 
was amplified by PCR using plasmid pKER2 and the oli- 
gonucleotides PCAP3B and PCAP21 as primers. After di- 
gestion with NdeI (a target site engineered in PCAP3B) 
and PstI, the cap3B gene was ligated to pT7-7 previously 
digested with the same enzymes, introduced by transforma- 
tion into E. coli DH10B, and the recombinant plasmid 
pTBP3 was isolated from one chloramphenicol/ampicil l in- 
P cop3B Ps H 
I ) .4" / /A / / / / / / / / / /KK;  X~ pKER2 
Nde! Ps f I /  ~ Hind= ~ 5.6kb "]] 
N ps l 1 E 
~ $ 
3B 
N 
~cop ~8 
Figure 2. Schematic representation of the expression 
plasmids pTBP3 and pLSE3B. Triangles represent the 
location and orientation ofthe oligonucleotides prim- 
ers, as described inthe legend to Fig. 1. The PCAP3B 
primer includes the NdeI (N) restriction site. E, 
EcoP, l; H, HindlII; P, PvulI; Ps, Pstl. bla, Em and Tc 
represent the genes encoding theampicillin-, erythro- 
mycin/lincomycin-, and tetracycline-resistance traits, 
respectively (19). (t)10 indicates the promoter of the 
gene 10 of T7 bacteriophage recognized by the T7 
RNA polymerase. 
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resistant clone and used to transform E. coli BL21(DE3) 
pLysS. The presence ofpLysS was an absolute requirement 
for successful transformation with pTBP3, since prelimi- 
nary experiments u ing the E. coli strain BL21(DE3) did 
not yield any transformants (not shown). To clone cap3B 
into pLSE1, a plasmid able to replicate both in E. coli and 
S. pneumoniae (19), the 2-kb Pvul I /Hindl I I  fragment of  
pKER2 was ligated to pLSE1 previously digested with 
EcoRV and HindlII (Fig. 2). The ligation mixture was 
used to transform E. coli C600, and pLSE3B was selected 
by screening among the erythromycin-resistant transfor- 
mants. It was expected that expression of  cap3B would be 
under the control of  the tetracycline promoter of  the vec- 
tor plasmid, as it has been reported for other genes (28 and 
references therein). 
For T7 expression, E. coli cells harboring pTBP3 were 
grown in LB medium up to an OD600 of 0.6 and induced 
with isopropyl-IB-D-thiogatactopyranoside (IPTG; 1 mM). 
A 49-kD protein, corresponding to the expected size of  
Cap3B (11), was observed after a 90-rain induction, as 
shown by SDS-PAGE of cellular crude extracts (Fig. 3 A). 
This band was cut from the gel, and determination of  the 
NH2-terminal amino acid sequence yielded Met-Tyr-Thr-  
Phe-Ile-Leu, thus confirming the sequence deduced from 
the nucleotide analysis of the cap3B gene (11). Control cells 
containing pT7-7 did not show any additional protein 
band over a 3-h time course experiment. 
Synthesis and Analysis of the Pneumococcal Type 3 Polysac- 
charide in E. coli. Sonicated extracts prepared from both 
induced and uninduced cultures of  E. coli BL21 (DE3)pLysS 
harboring pTBP3 contained type 3 polysaccharide, asdem- 
onstrated by immunoprecipitation with a type-specific an- 
tiserum (Fig. 3 B). The amount of  type 3 polysaccharide 
found in uninduced E. coli cells was 10-25% of that of  in- 
duced cultures. This result is in agreement with an incom- 
plete repression f the T7 promoter in the host strain used 
here, as it has been reported previously (16). On the other 
hand, IPTG-induced E. coli cultures ynthesized as much as 
1-5% of the amount of  type 3 polysaccharide synthesized 
by S. pneumoniae (between 10 and 50 ~g per 108 cells; our 
unpublished results). Uninduced E. coli cultures harboring 
pTBP3 were used to determine the subcellular localization 
of  the pneumococcal polysaccharide. It was found that a 
substantial amount (~40%) of the type 3 polysaccharide 
was localized in the periplasmic space of E. coli, 40-50% 
was in the cytoplasm, and the rest were in the membrane 
fraction (not shown). This polysaccharide was further char- 
acterized by gel filtration chromatography, showing it to be 
highly polymerized as it eluted in the void volume of a 
Sepharose CL-4B column (not shown). These results indi- 
cated that Cap3B is actually the enzyme that synthesizes the 
type 3 pneumococcal polysaccharide. 
Formation of Binary Cells of Pneumococcus by Transformation 
with the cap3B Gene. Pneumococcal strains that produce 
simultaneously two distinct capsular polysaccharides have 
been described previously (see reference 29 for a review). 
These strains arise by transformation reactions between 
pneumococci-expressing capsules that contain hexuronic 
acids, such as those belonging to serotypes 1 and 3. When 
the plasmid pLSE3B was introduced by transformation i to 
the $1 pneumococcal strain M25, all the lincomycin-resis- 
rant transformants expressed both type 1 and type 3 capsu- 
lar polysaccharides, as determined by the Quellung reaction 
(data not shown), as well as by immunodiffusion a alysis of  
Figure 3. Expression fthe Cap3B polysaccharide synthase and synthe- 
sis of type 3 pneumococcal polysaccharide by E. coli containing the re- 
combinant plasmid pTBP3. (A), BL21(DE3)pLysS cells containing either 
pTBP3 or pT7-7 vector alone w re grown to an OD600 of 0.6, induced 
with l mM IPTG, and the crude sonicated extracts were analyzed by 10% 
by SDS-PAGE. Lane 1, extracts from bacteria containing pT7-7. Lanes 2 
and 3, extracts from bacteria harboring pTBP3 and removed before in- 
duction with IPTG and after 90 rain induction, respectively. The location 
of the overexpressed Cap3B is indicated by an arrow. The molecular mass 
of the standards are indicated on the left. (B), Double immunodiffusion test. 
Wells labeled 1-3 contain extracts corresponding to samples 1-3 of A, re- 
spectively. Well 4 contains purified type 3 pneumococcal polysaccharide. 
The center well received type 3 antiserum. Each well received 10 Ixl of 
the corresponding sample. 
Figure 4. Double immunodiffusion in agarose of capsulated pneumo- 
cocci, l-5indicate antisera against pneumococcal po ysaccharides of types 
1-3, 5, and 8, respectively. A-E designate capsular polysaccharides puri- 
fied from the S. pneumoniae strains ofserotypes 1-3, 5, and 8, respectively. 
a-d correspond to binary transformants of the following serotypes: 1/3, 
2/3, 5/3, and 8/3, respectively, e and f contains polysaccharide pr pared 
from $3 + transforrnants of Mll and M31, respectively. Each well re- 
ceived 10 ~tl of the corresponding sample. 
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cell extracts with specific antisera (Fig. 4). This result was 
not restricted to serotypes 1 and 3 because pneumococcal 
cells belonging to serotypes 2, 5, and 8, all of them produc- 
ing capsules that contain glucuronic acid (30), also gave rise 
to binary transformants when transformed with pLSE3B. 
Furthermore, strains M l l  and M31, two $2- laboratory 
derivatives of the rough strain R36A, also synthesized type 
3 capsule (but not type 2) when transformed with pLSE3B 
(Fig. 4). In every case, the type 3 polysaccharide produced 
was of high Mr, as demonstrated by gel filtration (not 
shown). 
Discussion 
The molecular organization of the genes implicated in 
capsulation of S. pneumoniae is currently being studied. As 
in Gram-negative bacteria (31), genes involved in the syn- 
thesis of the sugar precursors and the polymerization reac- 
tions appear to be specific for any given capsular type also 
in S. pneumoniae (7-12, 32). Type 3--specific genes are ar- 
ranged as an operon, and the promoter is located just up- 
stream of the first specific gene (cap3A) (11). In type 19F, 
however, Guidolin and co-workers (32) suggested that up- 
stream of the type-specific genes, the transcript included 
several open reading frames common to all pneumococci. 
Thus, it appears that diverse functional organizations of the 
capsular genes may exist in different pneumococcal sero- 
types. 
Very few gene products thought o be implicated in cap- 
sule formation in Gram-positive bacteria have been identi- 
fied biochemically so far. Among these, the S. pyogenes 
hasA codes for an enzyme that directs hyaluronic acid bio- 
synthesis, the component of the capsule of this microor- 
ganism (33-35). It has been shown that HasA is necessary 
and sufficient o synthesize hyaluronic acid both in Entero- 
coccusfaecalis and in E. coli, provided that the host bacterium 
produces the corresponding sugar nucleotides (UDP-GlcA 
and UDP-N-acetyl glucosamine) (36). This relationship 
appears also to be the case for the pneumococcal Cap3B 
synthase (Fig. 3 B). In addition to the omnipresent UDP- 
Glc, which plays a central role in the biosynthesis of most 
cellular polysaccharides, UDP-GlcA has been found both 
in E. coli (37-39) and in some S. pneumoniae s rotypes (40). 
Since type 1 capsule contains galacturonic acid, a specific 
epimerase reaction is required to convert UDP-GlcA to 
UDP-GalA (41). Furthermore, since pTBP3 and pLSE3B 
contain exclusively the cap3B gene as an insert (Fig. 2), it is 
clear that the Cap3B synthase has both UDP-Glc and 
UDP-GlcA glycosyltransferase ctivities and possibly syn- 
thesizes the type 3 polysaccharide in a processive manner 
by monomer addition. In S. pyogenes, Dougherty and van 
de Rijn (34) speculated that HasA synthase may catalyze 
transfer of only one of the two sugars, N-acetyl glu- 
cosamine, to the nascent hyaluronic acid chain. Neverthe- 
less, DeAngelis and Weigel (35) concluded that HasA is a 
synthase that possesses both glycosyl transferase activities 
that are required to polymerize hyaluronic acid. 
In E. coli and in other capsulated Gram-negative bacteria, 
the capsular polysaccharide determinants were shown to 
contain three phenotypically distinct regions associated 
with polysaccharide expression. Region 1 is necessary for 
the transport of mature, lipid-linked polysaccharide across 
the outer membrane and its assembly into a capsule. Re- 
gion 2 is serotype specific and codes for the enzymes in- 
volved in synthesis and polymerization. Region 3 is re- 
sponsible for the translocation of the polysaccharide across 
the cytoplasmic membrane (42). The KpsMT proteins coded 
by genes located in region 3 and belonging to the family of 
ABC transporters (43) are capable of transporting a variety 
of acidic polysaccharides to the periplasm. Of particular in- 
terest is the finding reported here that ~50% of the pneu- 
mococcal type 3 polysaccharide synthesized in E. coli ap- 
pears in the periplasmic space, although we can not 
determine whether the mechanism for this transport is the 
same as that for the homologous polysaccharide. 
In Gram-positive bacteria, the mechanism ofpolysaccha- 
ride transport has not been characterized sofar. In type 19F 
pneumococci, it has been suggested that some of the genes 
located upstream of the specific capsular cluster (namely, 
cps 19fA-D) might be responsible for the transport of the in- 
tracellularly synthesized capsular polysaccharide (32). How- 
ever, we have recently shown that the genes corresponding 
to those described by Guidolin et al. are not functional in 
pneumococci belonging to the type 3 serotype (11). The 
results reported here strongly suggest hat another still- 
unknown mechanism may be responsible for the export of 
the capsular polysaccharide through the cytoplasmic mem- 
brane. 
We have shown that the presence of the type 3 pneumo- 
coccal polysaccharide synthase is sufficient to direct the 
synthesis of a type 3 capsule in S. pneumoniae strains be- 
longing to serotypes 1, 2, 5, and 8 (Fig. 4). It can be as- 
sumed that the mechanism of polysaccharide transport of 
the recipient cell is used for the formation of a type 3 cap- 
sule in the binary transformants. Early experimental evi- 
dence showed that when an unencapsulated mutant of type 
3 is transformed with DNA from a capsulated strain of type 
1, a minority (2-5%) of the transformants were of the bi- 
nary type, i.e., they reacted with both types 1 and 3 antisera 
and synthesized two distinct polysaccharides (44). Transfor- 
mation experiments with these stable binary strains sug- 
gested that a supernumerary gene cluster (i.e., type 1) had 
been inserted, presumably by homologous recombination, 
at a repeat element unlinked to the capsule locus (reviewed 
in 29). Recently, we have shown that copies of the DNA 
sequences located upstream of the cap3ABC operon are 
present in different locations in the genome (8). In contrast 
with this situation, the transformants described here re- 
suited from the expression of the plasmid-borne cap3B 
gene. In conclusion, provided that the corresponding sugar 
nucleotide precursors (UDP-Glc and UDP-GlcA) are present, 
cap3B appears to be the only gene required to direct type 3 
polysaccharide biosynthesis n the pneumococcal strains or 
in E. coli. 
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